Shane Ward's Net Worth
$229 Thousand
Who is Shane Ward?
Shane Ward does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cidara Therapeutics, Inc., BELLICUM PHARMACEUTICALS, INC, and Versartis, Inc..
SEC CIK
Shane Ward's CIK is 0001638380
Past Insider Trading and Trends
2017 was Shane Ward's most active year for acquiring shares with 5 total transactions. Shane Ward's most active month to acquire stocks was the month of February. 2017 was Shane Ward's most active year for disposing of shares, totalling 4 transactions. Shane Ward's most active month to dispose stocks was the month of February. 2019 saw Shane Ward paying a total of $9,821.60 for 98,000 shares, this is the most they've acquired in one year. In 2017 Shane Ward cashed out on 4,291 shares for a total of $61,191.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $0.67
COO & CLO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +60.37% | 120K |
—
|
—
| 318.77K |
Mar 15
| |||
Form 4
| -9.34% | -20.47K |
$0.67 | -$13,712.82 | 198.77K |
Mar 11
| |||
Form 4
| +149.77% | 126.67K |
—
|
—
| 211.24K |
Mar 27
| |||
Form 4
| -4.87% | -4.33K |
$1.53 | -$6,623.37 | 84.58K |
Mar 13
| |||
Form 4
|
∞
| 80.91K |
$0.83 | -$19,191.26 | 80.91K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BELLICUM PHARMACEUTICALS, INC (BLCM) Snapshot price: $0.082
Sr VP and Chief Legal SO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.39% | -107.00 |
$7.63 | -$816.41 | 1.88K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +77.72% | 8K |
$1.23 | $9,821.60 | 18.29K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| -10.65% | -1.06K |
$2.09 | -$2,225.85 | 8.94K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Versartis, Inc. (ARAV) No price found
SVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.00% | -4.12K |
$1.80 | -$7,412.40 | 201.56K |
Feb 8
| |||
Form 4
| +82.70% | 93.1K |
—
|
—
| 205.67K |
Dec 20
| |||
Form 4
| +21.60% | 20K |
—
|
—
| 112.57K |
Nov 28
| |||
Form 4
| -0.83% | -776.00 |
$2.55 | -$1,978.80 | 92.57K |
Oct 19
| |||
Form 4
| +156.81% | 57K |
—
|
—
| 93.35K |
Oct 6
| |||
Form 4
| -5.32% | -2.04K |
$19.01 | -$38,794.52 | 36.35K |
Mar 14 - Mar 15
| |||
Form 4
| +99.28% | 19.13K |
$13.85 | -$20,417.85 | 38.39K |
Jan 27 - Jan 30
| |||
Form 4
| +35.05% | 5K |
—
|
—
| 19.27K |
Oct 11
| |||
Form 4
| +1,027.67% | 13K |
—
|
—
| 14.27K |
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||